p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Tokuda, Haruhiko ^a,b   Hatakeyama, Daijiro ^b   Shibata, Toshiyuki ^b   Akamatsu, Shigeru ^b   Oiso, Yutaka ^c   Kozawa, Osamu ^b  

^a CHUBU NATIONAL HOSPITAL   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone morphogenetic protein; Mitogen activated protein kinase; Osteoblast; Vascular endothelial growth factor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; BONE MORPHOGENETIC PROTEIN 4; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P42; PROTEIN P44; PROTEIN P70; RAPAMYCIN; S6 KINASE; SYNAPTOPHYSIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0037840398     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00300.2002     Document Type: Article

References (36)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
2. Centrella M, Horowitz MC, Wozney JM, and McCarthy TL. Transforming growth factor-β gene family members and bone. Endocr Rev 15: 27-39, 1994.
3. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
4. Erlebacher A, Filvaroff EH, Gitelman SE, and Derynck R. Toward a molecular understanding of skeketal development. Cell 80: 371-378, 1995.
5. Favata MF, Horiuchi KY, Monos EJ, Daulerio AJ, Stradley DA, Feeser WS, VanDyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
6. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, and Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28: 491-498, 2001.
7. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628, 1999.
8. Goad DL, Rubin J, Wang H, Tashjian AH Jr, and Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor-I. Endocrinology 137: 2262-2268, 1996.
9. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, and Rodan SB. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93: 2490-2496, 1994.
10. Harland RM. The transforming growth factor β family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers. Proc Natl Acad Sci USA 91: 10243-10246, 1994.
11. Hazzalin CA, Le Panse R, Cano E, and Mahadevan LC. Anisomycin selectively desensitized signaling components involved in stress kinase activation and fos and jun induction. Mol Cell Biol 18: 1844-1854, 1998.
12. Heldin C-H, Miyazono K, and ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
13. Itoh S, Itoh F, Goumans MJ, and ten Dijke P. Signaling of transforming growth factor-β family members through Smad proteins. Eur J Biochem 267: 6954-6967, 2000.
14. Kawabata M, Imamura T, and Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9: 49-61, 1998.
15. Kozawa O, Hatakeyama D, and Uematsu T. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. J Cell Biochem 84: 583-589, 2002.
16. Kozawa O, Matsuno H, and Uematsu T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 81: 430-436, 2001.
17. 2α stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol Endocrinol Metab 272: E208-E211, 1997.
18. Kummer JL, Rao PK, and Heidenreich KA. Apoptosis induced by withdrawal of trophic factor is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272: 20490-20494, 1997.
19. Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, and Crabtree GR. Rapamycin selectively inhibits interleukin-2 activation of p70S6 kinase. Nature 358: 70-73, 1992.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
21. Lali FV, Hunt AE, Turner SJ, and Foxwell BM. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem 275: 7395-7402, 2000.
22. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, and Landvatter SW. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
23. Lou J, Tu Y, Li S, and Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 268: 757-762, 2000.
24. Massague J. TGFβ signal transduction. Annu Rev Biochem 67: 753-791, 1998.
25. Miwa M, Kozawa O, Tokuda H, and Uematsu T. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C. Endocrinology 140: 5120-5125, 1999.
26. Neufeld G, Cohen T, Gengrinovitch S, and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
27. Nijweide PJ, Burger EH, and Feyen JHM. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 86: 855-886, 1986.
28. Price DJ, Grove JR, Calvo V, Avruch J, and Bierer BE. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257: 973-977, 1992.
29. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 32: 737-744, 1994.
30. Sudo H, Kodama H, Amagai Y, Yamamoto S, and Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198, 1983.
31. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Drescoll PC, Woscholski R, Parker PJ, and Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602, 2001.
32. Vinals F, Lopez-Rovira T, Rosa JL, and Ventura F. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett 510: 99-104, 2002.
33. Vlahos CJ, Matter WF, Hui KY, and Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
34. Widmann C, Gibson S, Jarpe MB, and Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999.
35. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, and Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation. J Cell Biol 113: 681-687, 1991.
36. Yamaguchi A, Ishizuya T, Kitou N, Wada Y, Katagiri T, Wozney JM, Rosen V, and Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell line, ST-2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220: 366-371, 1996.